Naming of the Kenneth W. McArthur Neurodegenerative Research Floor
June 25, 2026
The Dementia Therapeutics Innovation Initiative (DTII) was launched in 2025 thanks to the philanthropy of Kenneth W. McArthur. A recent Give UBC story ‘Loyal donor-alum’s generosity advances Alzheimer’s research at UBC’ highlights the generosity of the McArthurs and the Aune Foundation, whose transformational support is helping to advance innovative Alzheimer’s research and strengthen UBC’s efforts […]
DTII Research Associate and donors featured in Give UBC’s Aspire Newsletter
December 22, 2025
Dr. Stefan Wendt, a DTII research associate who was instrumental in the development of the ‘mini-brain’ neurosphere model, was recently interviewed for Give UBC’s November 2025 Aspire Newsletter. ‘The brains that resist Alzheimer’s‘ describes the mystery of resilience in Alzheimer’s disease and the work being performed to map the genes involved in Alzheimer’s and resilience. […]
DTII Researchers Featured in UBC Faculty of Medicine’s Pathways Magazine
December 15, 2025
Dementia Therapeutics Innovation Initiative lead researchers Drs. Haakon Nygaard, Brian MacVicar, and Freda Miller were recently featured in Issue 8 of UBC Faculty of Medicine’s digital magazine, Pathways. The article, titled ‘Unravelling the mystery behind Alzheimer’s resilience‘, explores the concept of resilience in Alzheimer’s disease and explains the work being performed by the DTII to […]